Literature DB >> 18936185

Toll-like receptor 9 modulates immune responses to Aspergillus fumigatus conidia in immunodeficient and allergic mice.

Hemanth Ramaprakash1, Toshihiro Ito, Theodore J Standiford, Steven L Kunkel, Cory M Hogaboam.   

Abstract

The role of Toll-like receptor 9 (TLR9) in antifungal responses in the immunodeficient and allergic host is unclear. We investigated the role of TLR9 in murine models of invasive aspergillosis and fungal asthma. Neutrophil-depleted TLR9 wild-type (TLR9(+/+)) and TLR9-deficient (TLR9(-/-)) mice were challenged with resting or swollen Aspergillus fumigatus conidia and monitored for survival and lung inflammatory responses. The absence of TLR9 delayed, but did not prevent, mortality in immunodeficient mice challenged with resting or swollen conidia compared to TLR9(+/+) mice. In a fungal asthma model, TLR9(+/+) and TLR9(-/-) mice were sensitized to soluble A. fumigatus antigens and challenged with resting or swollen A. fumigatus conidia, and both groups of mice were analyzed prior to and at days 7, 14, and 28 after the conidium challenge. When challenged with resting conidia, TLR9(-/-) mice exhibited significantly lower airway hyper-responsiveness compared to the TLR9(+/+) groups. In contrast, A. fumigatus-sensitized TLR9(-/-) mice exhibited pulmonary fungal growth at days 14 and 28 after challenge with swollen conidia, a finding never observed in their allergic wild-type counterparts. Increased fungal growth in allergic TLR9(-/-) mice correlated with markedly decreased dectin-1 expression in whole lung samples and isolated dendritic cell populations. Further, whole lung levels of interleukin-17 were lower in allergic TLR9(-/-) mice compared to similar TLR9(+/+) mice. Together, these data suggest that TLR9 modulates pulmonary antifungal immune responses to swollen conidia, possibly through the regulation of dectin-1 expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18936185      PMCID: PMC2612288          DOI: 10.1128/IAI.00998-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  57 in total

Review 1.  Pathophysiology and immunology of allergic bronchopulmonary aspergillosis.

Authors:  R B Moss
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

Review 2.  Aspergillus and asthma--any link?

Authors:  C M Hogaboam; K J Carpenter; J M Schuh; K F Buckland
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

Review 3.  Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus.

Authors:  T J Walsh; E Roilides; K Cortez; S Kottilil; J Bailey; C A Lyman
Journal:  Med Mycol       Date:  2005-05       Impact factor: 4.076

4.  The human beta-glucan receptor is widely expressed and functionally equivalent to murine Dectin-1 on primary cells.

Authors:  Janet A Willment; Andrew S J Marshall; Delyth M Reid; David L Williams; Simon Y C Wong; Siamon Gordon; Gordon D Brown
Journal:  Eur J Immunol       Date:  2005-05       Impact factor: 5.532

5.  Therapeutic targeting of CCR1 attenuates established chronic fungal asthma in mice.

Authors:  Kristin J Carpenter; Jillian L Ewing; Jane M Schuh; Traci L Ness; Steven L Kunkel; Monica Aparici; Montserrat Miralpeix; Cory M Hogaboam
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

6.  TLRs govern neutrophil activity in aspergillosis.

Authors:  Silvia Bellocchio; Silvia Moretti; Katia Perruccio; Francesca Fallarino; Silvia Bozza; Claudia Montagnoli; Paolo Mosci; Grayson B Lipford; Lucia Pitzurra; Luigina Romani
Journal:  J Immunol       Date:  2004-12-15       Impact factor: 5.422

7.  Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.

Authors:  E Roilides; A Dimitriadou-Georgiadou; T Sein; I Kadiltsoglou; T J Walsh
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis.

Authors:  B Mehrad; R M Strieter; T J Standiford
Journal:  J Immunol       Date:  1999-02-01       Impact factor: 5.422

9.  IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance.

Authors:  Teresa Zelante; Antonella De Luca; Pierluigi Bonifazi; Claudia Montagnoli; Silvia Bozza; Silvia Moretti; Maria L Belladonna; Carmine Vacca; Carmela Conte; Paolo Mosci; Francesco Bistoni; Paolo Puccetti; Robert A Kastelein; Manfred Kopf; Luigina Romani
Journal:  Eur J Immunol       Date:  2007-10       Impact factor: 5.532

10.  Mold sensitization is common amongst patients with severe asthma requiring multiple hospital admissions.

Authors:  B Ronan O'Driscoll; Linda C Hopkinson; David W Denning
Journal:  BMC Pulm Med       Date:  2005-02-18       Impact factor: 3.317

View more
  34 in total

1.  Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection.

Authors:  Benoit Briard; Rajendra Karki; R K Subbarao Malireddi; Anannya Bhattacharya; David E Place; Jayadev Mavuluri; Jennifer L Peters; Peter Vogel; Masahiro Yamamoto; Thirumala-Devi Kanneganti
Journal:  Nat Microbiol       Date:  2018-12-03       Impact factor: 17.745

2.  DNA from Porphyromonas gingivalis and Tannerella forsythia induce cytokine production in human monocytic cell lines.

Authors:  S E Sahingur; X-J Xia; S Alamgir; K Honma; A Sharma; H A Schenkein
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 3.  Innate immunity to Aspergillus species.

Authors:  Stacy J Park; Borna Mehrad
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

4.  TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking.

Authors:  Pia V Kasperkovitz; Michael L Cardenas; Jatin M Vyas
Journal:  J Immunol       Date:  2010-11-08       Impact factor: 5.422

Review 5.  Aspergillus fumigatus and aspergillosis: From basics to clinics.

Authors:  A Arastehfar; A Carvalho; J Houbraken; L Lombardi; R Garcia-Rubio; J D Jenks; O Rivero-Menendez; R Aljohani; I D Jacobsen; J Berman; N Osherov; M T Hedayati; M Ilkit; D James-Armstrong; T Gabaldón; J Meletiadis; M Kostrzewa; W Pan; C Lass-Flörl; D S Perlin; M Hoenigl
Journal:  Stud Mycol       Date:  2021-05-10       Impact factor: 16.097

6.  Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.

Authors:  Hemanth Ramaprakash; Takehiko Shibata; Karen E Duffy; Ugur B Ismailoglu; Rachel M Bredernitz; Ana Paula Moreira; Ana L Coelho; Anuk M Das; Natalie Fursov; Geoffrey L Chupp; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2011-05-14       Impact factor: 4.307

7.  The cell biology of the innate immune response to Aspergillus fumigatus.

Authors:  Michael K Mansour; Jenny M Tam; Jatin M Vyas
Journal:  Ann N Y Acad Sci       Date:  2012-12       Impact factor: 5.691

8.  The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22.

Authors:  Lauren M Lilly; Melissa A Gessner; Chad W Dunaway; Allison E Metz; Lisa Schwiebert; Casey T Weaver; Gordon D Brown; Chad Steele
Journal:  J Immunol       Date:  2012-08-29       Impact factor: 5.422

9.  Intranasal CpG therapy attenuated experimental fungal asthma in a TLR9-dependent and -independent manner.

Authors:  Hemanth Ramaprakash; Cory M Hogaboam
Journal:  Int Arch Allergy Immunol       Date:  2009-12-16       Impact factor: 2.749

10.  MDA5 Is an Essential Sensor of a Pathogen-Associated Molecular Pattern Associated with Vitality That Is Necessary for Host Resistance against Aspergillus fumigatus.

Authors:  Xi Wang; Alayna K Caffrey-Carr; Ko-Wei Liu; Vanessa Espinosa; Walburga Croteau; Sourabh Dhingra; Amariliz Rivera; Robert A Cramer; Joshua J Obar
Journal:  J Immunol       Date:  2020-10-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.